BPC-157 (10mg or 20mg) Research Use Only DISCLAIMER: All products listed on this site are for research purposes ONLY
Interstitial cystitis: In a trial of 12 women (ages 39-76) with moderate to severe interstitial cystitis unresponsive to conventional treatment, a single 10 mg BPC-157 injection led to complete symptom resolution in 10 patients and 80% improvement in 2, with no reported adverse effects (18) Knee pain: A retrospective study found that 11 of the 12 patients (91.6%) receiving BPC 157 as an intra-articular injection had significant improvement in knee pain, whereas 1 patient (8.3 %) had no improvement (19) Efficacy of BPC 157 Delivery Methods BPC-157 can be administered orally, topically, or via injection
An initial 4-8 week assessment period allows evaluation of individual response and tolerance before committing to extended therapy
Additional information Calculate Your Body Mass Index
The gastric juice origin is interesting BPC is a protein that exists naturally in the stomach, and BPC-157 is a stable synthetic fragment of that protein
Tirzepatide Once Weekly for the Treatment of Obesity: Participants in this study complete a 60-week Weight-Loss Period on Tirzepatide, followed by a 52-week Weight Maintenance Period, where they are assigned to either Tirzepatide 5 mg, the maximum tolerated dose of Tirzepatide, and saw successful results